- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
- Lower GI
- Upper GI
- Video and telephone consultations
- Home chemotherapy
I am a Medical Oncology Consultant for the Gastrointestinal Oncology Service at University College London Hospitals NHS Foundation Trust and Honorary Associate Professor at the UCL Cancer Insitute. I treat oesophageal, stomach, small bowel, colorectal and hepatobiliary cancers, as well as cancers of unknown primary. I am the UCLH Clinical Lead for the Cancer of Unknown Primary Service and the Acute Oncology Service.
My research interests include immunotherapy for GI malignancies and Cancer of Unknown Primary. I am Chief Investigator or Principal Investigator for a number of GI or CUP immuno-oncology Phase 2 and 3 trials, including KEYNOTE 177, NEOPRISM-CRC, LEAP 17, KEYNOTE 859, KEYNOTE 811, KEYNOTE 975, MATTERHORN, VESTIGE and CUPISCO.
I am Chair of the NCRI MUO-CUP Workstream as part of the Living With and Beyond Cancer CSG, and a member of the NCRI Colorectal Advanced and Adjuvant Disease Subgroup. I am the Principal Investigator of the UCL-UCLH GI + CUP Cancer Translational Research Biobank and a collaborator with the GI Oncology and CUP subgroups at the UCL Cancer Institute and Francis Crick Institute. I am a member of ASCO, ESMO and the Association of Cancer Physicans (UK).
Areas of interest
Immunotherapy for gastrointestinal cancers
Cancer of Unknown Primary
Novel clinical trials and trial design
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (>50)
Follow-up out-patient consultation - remote - (5-50)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)